Inventor · disambiguated record
Paul A. Fitzpatrick
Also filed as: FITZPATRICK PAUL · FITZPATRICK PAUL A · FITZPATRICK PAUL ANDREW
13 granted patents·8 pending applications·358 citations·filing 1998–2022
93Inventor score
Top patents by PatentIndex Score
21 records- 0198US7531341B1Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2006·Granted May 12, 2009·87 cites·6 claims
- 0297US7534595B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2007·Granted May 19, 2009·79 cites·34 claims
- 0396US7537923B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2008·Granted May 26, 2009·49 cites·9 claims
- 0494US7790433B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2009·Granted Sep 7, 2010·32 cites·6 claims
- 0591US6569661B1Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereofBIOMARIN PHARM INC·Filed 2000·Granted May 27, 2003·63 cites·10 claims
- 0688US7553653B2Variants and chemically-modified variants of phenylalanine ammonia-lyaseBIOMARIN PHARM INC·Filed 2005·Granted Jun 30, 2009·34 cites·7 claims
- 0780US11505790B2Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2019·Granted Nov 22, 2022·1 cites·14 claims
- 0880US10221408B2Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2016·Granted Mar 5, 2019·3 cites·18 claims
- 0977US6972124B2Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2003·Granted Dec 6, 2005·8 cites·5 claims
- 1076US2024035013A1Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 1163US6866844B2Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2002·Granted Mar 15, 2005·2 cites·47 claims
- 1259US2005287133A1Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2005·Application pending·0 cites
- 1356US7888038B2Bak binding protein, DNA encoding the protein, and methods of use thereofGENENTECH INC·Filed 2006·Granted Feb 15, 2011·0 cites·15 claims
- 1454US2012142099A1Novel bak binding protein, dna encoding the protein, and methods of use thereofKIEFER MICHAEL C·Filed 2011·Application pending·0 cites
- 1552US2010278802A1Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2010·Application pending·0 cites
- 1651US2008260715A1Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2007·Application pending·0 cites
- 1751US2013039898A1Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2011·Application pending·0 cites
- 1849US7316915B2Bak binding protein, DNA encoding the protein, and methods of use thereofTANOX INC·Filed 2002·Granted Jan 8, 2008·0 cites·25 claims
- 1946US2006040348A1Methods for producing and purifying recombinant alpha-L-iduronidaseQIN MINMIN·Filed 2003·Application pending·0 cites
- 2043US2002146802A1Methods for producing and purifying recombinant alpha-L-iduronidaseFiled 2001·Application pending·0 cites
- 2129US6441135B1Bak binding protein, DNA encoding the protein, and methods of use thereofTANOX INC·Filed 1998·Granted Aug 27, 2002·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →